Press Releases Stenocare A/S

Equities

Market Closed - Nasdaq Copenhagen Other stock markets 10:59:34 2024-05-16 am EDT			5-day change	1st Jan Change
4.99 ^DKK	+1.42%		-2.16%	+96.46%

May. 02	Stenocare A/S Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
Apr. 18	Stenocare A/S Announces That the New STENOCARETHC/CBD Medical Cannabis Oil Product Available for Sale in Denmark	CI

COMMUNIQUE FROM THE ANNUAL GENERAL MEETING OF STENOCARE	May. 14	AQ
Interim Report First Quarter 2024	May. 02	AQ
Notice to Annual General Meeting in STENOCARE A/S	Apr. 22	AQ
From today, the new STENOCARE THC/CBD medical cannabis oil product is available for sale in Denmark	Apr. 18	AQ
STENOCARE A/S publishes Annual Report 2023	Mar. 14	AQ
New Stenocare product ready for sale in Australia	Mar. 12	AQ
Major milestone reached: STENOCARE receives approval to sell a new medical cannabis oil product in Denmark	Feb. 26	AQ
Interim Report Fourth Quarter 2023	Feb. 22	AQ
Communiqué from extraordinary general meeting in STENOCARE	Feb. 05	AQ
STENOCARE financing need has been completed as planned incl solution for refinancing of debt	Jan. 12	AQ
Notice to Extraordinary General Meeting in STENOCARE A/S	Jan. 12	AQ
STENOCARE: How to receive TO1 Warrant Compensation	Dec. 29	AQ
STENOCARE A/S: Consolidation of founder's shareholdings	Dec. 21	AQ
TO1 Warrant Exercise subscribed to 76.7%	Dec. 21	AQ
Founders of Stenocare join directed issue	Dec. 19	AQ
Shareholder invests 4.7 mDKK in STENOCARE A/S	Dec. 19	AQ
STENOCARE: The deadline for using TO1 Warrants is Dec 19	Dec. 17	AQ
STENOCARE expands in Australia	Dec. 14	AQ
STENOCARE: The deadline for trading TO1 Warrants is Dec 15	Dec. 13	AQ
STENOCARE Executive team to exercise TO1 Warrants	Dec. 11	AQ

No results for this search